Iron bisglycinate vs ferrous fumarate: the chelate, the iron and the label
Ferrous bisglycinate is a 2:1 chelate of ferrous iron and glycine carrying 26.0–28.0% elemental iron; ferrous fumarate is an iron salt carrying 31.0–33.0%. The fumarate therefore carries the same iron in about 83% of the mass, while the bisglycinate dissolves in water and the fumarate does not. A swap changes the fill weight, the ingredient list and the market file, not only the word on the specification.
The bisglycinate is a 2:1 glycine chelate at about 27% iron; ferrous fumarate is a salt at about 33%, so the swap changes the mass on the scale as well as the name on the label.
A chelate and a salt are different structures
Ferrous bisglycinate is a coordination compound: one ferrous ion is bound by two glycinate ligands through the nitrogen and the carboxylate oxygen. Ferrous fumarate is an ionic salt of ferrous iron and fumaric acid. Both supply iron in the ferrous state, and both are described as iron sources, but the structures are not interchangeable in a formula or on a label.
| Property | Ferrous bisglycinate | Ferrous fumarate |
|---|---|---|
| Formula | C4H8FeN2O4 | C4H2FeO4 |
| CAS number | 20150-34-9 | 141-01-5 |
| Structure | Fe(II) with two glycinate ligands | Fe(II) fumarate salt |
| Iron, catalog window | 26.0–28.0% | 31.0–33.0% |
| Iron, theoretical | 27.4% | 32.9% |
| Appearance | Greenish-grey to off-white powder | Orange-red to reddish-brown powder |
| Solubility in water | Soluble; the solution is acidic | Practically insoluble; soluble in dilute acids |
| Ingredient-list name | Ferrous bisglycinate | Ferrous fumarate |
The two names are separate entries in a specification and on an ingredient list. “Iron” or “chelated iron” does not tell a reader which one is in the capsule, and a certificate that reports only iron does not settle the question either.
Iron content and the mass on the scale
The label declares elemental iron; the formulator weighs the material. The gap between the two windows is about six percentage points, which becomes a visible difference in fill weight as the dose rises.
| Target iron | Ferrous bisglycinate at 27.0% | Ferrous fumarate at 32.0% |
|---|---|---|
| 5 mg | 18.5 mg | 15.6 mg |
| 10 mg | 37.0 mg | 31.3 mg |
| 14 mg | 51.9 mg | 43.8 mg |
| 18 mg | 66.7 mg | 56.3 mg |
| 20 mg | 74.1 mg | 62.5 mg |
Use the assay on the lot certificate rather than the midpoint of the window. At the theoretical figures, 100 mg of bisglycinate carries 27.4 mg of iron, which needs 83 mg of fumarate at 32.9%. That 17% mass difference can change a capsule size, and it changes the amount of the other excipients that fit in the same fill.
Solubility, colour and the dosage form
The bisglycinate dissolves in water, so it suits a stick pack, a drink mix or any formula where the iron has to go into solution. The fumarate is practically insoluble and is normally used in capsules, tablets and dry blends where a small, compact dose matters. A suspension made with the fumarate needs a dispersion step and will settle; the bisglycinate starts as a solution.
Colour follows the chemistry. The bisglycinate is greenish-grey to off-white and blends into pale powders more easily; the fumarate is orange-red to reddish-brown and limits pale or white products. The fumarate's colour is also a field signal: an unexpectedly pale fumarate lot deserves a question about dilution, just as a brown bisglycinate lot deserves a question about oxidation.
Neither material is a drop-in for the other in a sensory or process sense. A tablet that ran well with one may need a different granulation, and a stick pack that dissolved one may show sediment with the other. The trial belongs in the real matrix, at the real share of the formula.
Oxidation and the matrix
Both materials carry ferrous iron, and ferrous iron oxidises to ferric when moisture and oxygen reach it. In the bisglycinate the iron is held by the glycine ligands in solution; in the fumarate the iron is released only as the salt dissolves. Which behaviour is more stable in a given formula is a test question, not a general rule, and the answer changes with pH, water activity and the reducing agents in the mix.
Iron can also catalyse the oxidation of lipids and some vitamins, and the rate follows the mobile fraction rather than the total. A soluble chelate in an aqueous mix and an insoluble salt in a dry blend present the iron differently. In a formula with ascorbic acid or a reducing sugar, the redox chemistry has to be measured in the matrix rather than assumed from the powder.
This page makes no absorption or tolerance claim for either form. Whether a chelate changes what happens in a person is a clinical question, and the evidence belongs in the brand's file; the label decision here is about mass, solubility, colour and the permitted name.
The label names the form
In the European Union, Directive 2002/46/EC provides the framework for food supplements and the lists of permitted vitamin and mineral forms. The exact iron form has to be matched to the current list and the member state's implementation, and the ingredient list must carry the name of the form actually present. Iron is declared in the nutrition declaration in mg against a 14 mg reference intake.
For a US label, the Supplement Facts panel declares iron in mg and as a percentage of the 18 mg Daily Value, while the ingredient list names the form. Iron-containing dietary supplements also carry the accidental-overdose warning required for the finished product. A switch from one form to the other is a relabelling exercise as well as a formulation change, and the market file has to be checked against the new name.
The conversion on the label is elemental iron, not salt mass. A formula that declares 14 mg of iron from the bisglycinate provides the same 14 mg from the fumarate, but the material mass falls from about 52 mg to about 44 mg. The nutrition declaration stays the same; the ingredient list and the fill weight do not.
When to choose which
Choose the bisglycinate when the formula needs a soluble iron source, a paler powder or a chelate that is named as such on the label, and when the lower iron fraction still fits the dose and the capsule. Choose the fumarate when the higher iron fraction, a compact tablet or a lower material mass matters and the colour and solubility fit the product. Both choices start with the label and the market file, not with the powder alone.
The two are not interchangeable gram for gram, and a quotation that names only “iron” has not quoted either one. The iron bisglycinate product page carries the chelate specification; the ferrous fumarate product page carries the salt specification; the ferrous gluconate page covers the third common ferrous option; the grade page covers mesh and dilution; the analytical methods are described in the methods library, and how lots are released is described under quality.
Related documents
Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.
Request a quotation